BMF-219

covalent menin inhibitor · Biomea Fusion Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BMF-219, covering 2025-02-07 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) [Phase 1, Phase 2]

See pricing